CPM Specifications Document
Fontan - Exercise:
OSMSC 0063_2000, 0063_3000, 0063_4000, 0064_2000, 0064_3000, 0064_4000, 0065_2000,
0065_3000, 0065_4000, 0075_2000, 0075_3000, 0075_4000, 0076_2000, 0076_3000, 0076_4000

May 1, 2013
Version 1

Open Source Medical Software Corporation
© 2013 Open Source Medical Software Corporation. All Rights Reserved.

1. Clinical Significance & Condition
Congenital heart defects are structural abnormalities present at birth that disrupt normal blood flow through
the heart, affecting 8 of every 1,000 newborns [1]. There are at least 18 documented types of congenital heart
defects, including coarcataion of the aorta, single ventricle defects, and complete atrioventricular canal defect
[2]. A large amount of anatomical variation is present within these individual congenital heart defect types.
In a study that examined congenital heart disease in the general population, the prevalence of single ventricle
defects was found to be 0.13 per 1000 children and 0.03 per 1000 adults [3]. Single ventricle defects cover a set
of cardiac abnormalities that result in one of the two ventricles being underdeveloped. With one ventricle being
of inadequate functionality or size, only one ventricle is available to pump the blood throughout the entire body.
Some examples of single ventricle defects include: hypoplastic left heart syndrome, pulmonary atresia, tricuspid
atresia, and double inlet left ventricle [2] [4]. Single ventricle heart patients are severely cyanotic at birth, and
these conditions are fatal with no interventions.
In order to provide adequate oxygenation, and separate the pulmonary and
systemic blood supplies, the blood returning to the heart is surgically redirected
to the pulmonary arteries, bypassing the heart. This surgical course typically
consists of three staged surgeries, a Blalock Taussig (BT) shunt and/or Norwood
procedure, a Glenn procedure, and finally a Fontan procedure (or total
cavopulmonary connection, TCPC).
The first stage is performed immediately after birth, and can vary among
patients depending on the defect and the pulmonary resistances. A systemic1 –Systemic-pulmonary shunt
pulmonary shunt (BT shunt, central shunt, or Sano shunt) is used to maintain Figure
for a single ventricle heart.
adequate ventricle volume load and providing sufficient pulmonary blood flow.
This is accomplished by connecting a systemic artery, such as the brachocephalic artery, to the pulmonary
arteries with a tube graft (Figure 1) [4] [5]. For situations where there is too much blood flow to the lungs, the
pulmonary artery can be narrowed with a synthetic band to restrict blood flow [4]. In patients with aortic
atresia, a neo-aorta is also constructed during the first stage of surgery. About 65-80% of hypoplastic left
ventricles have been found to be related to aortic atresia in several reviews [6]. During reconstruction of a neoaorta, the distal stump of the pulmonary artery and homograft tissue are used to
direct flow through the ascending aorta to the carotid and subclavian arteries [6, 7].

Figure 2 –Glenn procedure.
Arrows represent blood flow,
with blue being deoxygenated
blood, red being oxygenated
blood, and purple being a mix
of both.

The second stage is typically completed between the ages of 2-6 months [5]. The
Glenn procedure connects the superior vena cava to the right pulmonary artery in
order to improve oxygenation and decrease ventricle volume load (Figure 2) [8]. If
the patient had previously gone through a stage one procedure, it is removed during
stage two [4]. Oxygen saturation in patients who have undergone the Glenn
procedure typically is between 75-85% [4]. Another variation of the second stage is
the hemi-Fontan, where the pulmonary artery and superior vena cava are connected
through the right atrium and closed off to the rest of heart with a patch.

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 2

The third stage, a complete Fontan procedure, is typically completed between the ages of 1-5 years [5]. This
final stage redirects the inferior vena cava to the pulmonary artery. In combination with the previous stage,
deoxygenated blood bypasses the heart completely and is routed directly to the pulmonary artery so the single
ventricle is only pumping oxygenated blood throughout the body. A complete Fontan procedure is typically
done through a lateral tunnel or extracardiac method. A lateral
tunnel Fontan incorporates the wall of the atrium with a baffle
from the inferior vena cava to the pulmonary artery. On the
other hand, an extracardiac Fontan connects the inferior vena
cava to the pulmonary artery with a synthetic tube-shaped graft,
bypassing the heart altogether (Figure 3) [4]. In both methods, a
small hole, or fenestration, is often needed between the newly
formed channel and the atrium to reduce pressure in the Fontan
Figure 3 – Complete Fontan Circulation: Laterial Tunnel
circuit [4] [5]. A complete Fontan procedure increases oxygen Fontan (leff), Extracardiac Fontan (right). Arrows represent
blood flow, with blue being deoxygenated blood and red
saturation to virtually normal levels [4].
being oxygenated blood.

2. Clinical Data
Patient-specific volumetric image data was obtained to create physiological models and blood flow simulations.
Details of the imaging data used can be seen in Table 1. See Appendix 1 for details on image data orientation.
Table 1 – Patient-specific volumetric image data details (mm)

OSMSC ID

Modality

0063_X000
0064_X000
0065_X000
0075_X000
0076_X000

MR
MR
CT
MR
MR

Voxel Spacing
R
A
S
1.0000 0.5469 0.5469
1.5000 1.1719 1.1719
0.3691 0.3691 0.5000
1.5000 0.6836 0.6836
1.5000 0.6836 0.6836

Voxel Dimensions
R
A
S
120 512 512
64
256 256
512 512 296
80
512 512
88
512 512

Physical Dimensions
R
A
S
120 280
280
96
300
300
189 189
148
120 350
350
132 350
350

Available patient-specific clinical data collected for resting conditions can be seen in Table 2.
Table 2 – Available patient-specific clinical data

OSMSC ID

Age

Gender

BSA

CI

0063
0064
0065
0075
0076

3
6
5
17
27

M
F
F
F
F

0.63
0.71
0.68
1.55
0.68

3.8
2.7
2.8
2.3
3.8

Aorta
Aorta
Aorta
Psys
Pdia
Pavg
(mmHg) (mmHg) (mmHg)
80
50
63
95
63
78
102
67
78
140
95
108

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

IVC
Pavg
(mmhg)
11
9
11
18
15

LPA
RPA
SVC
Pavg
Pavg
Pavg
(mmHg) (mmHg) (mmHg)
10
10
11
6
6
9
7
9
11
17
17
18
14
14
15

Page 3

3. Anatomic Model Description
Anatomic models were created using customized SimVascular software (Simtk.org) and the image data
described in Section 2. See Appendix 2 for a description of modeling methods. See Table 3 for a visual summary
of the image data, paths, segmentations and solid model constructed.
Table 3 – Visual summary of image data, paths, segmentations and solid model.

OSMSC ID

Image Data

Paths

Paths and
Segmentations

Model

ID:
OSMSC0063
Age: 3
Gender: M

ID:
OSMSC0064
Age: 6
Gender: F

ID:
OSMSC0065
Age: 5
Gender: F

ID:
OSMSC0075
Age: 17
Gender: F

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 4

ID:
OSMSC0076
Age: 27
Gender: F

N/A

N/A

Details of anatomic models, such has number of outlets and model volume, can be seen in Table 4.
Table 4 – Anatomic Model details

OSMSC ID

Inlets

Outlets

Volume (cm3)

Surface Area (cm2)

Vessel Paths

2-D Segmentations

0063_X000
0064_X000
0065_X000
0075_X000
0076_X000

2
2
4
2
2

20
20
23
26
20

17.3673
21.2094
26.3423
68.5137
46.5195

90.6586
106.402
141.003
262.946
188.944

22
23
25
28
N/A

125
100
154
160
N/A

4. Physiological Model Description
In addition to the clinical data gathered for this model, several physiological assumptions were made in
preparation for running the simulation. See Appendix 3 for details.

5. Simulation Parameters & Details
5. 1

Simulation Parameters

See Appendix 4 and the peer-reviewed publication featuring these models [9] for information on the physiology
and simulation specifications. Solver parameters can be seen in Table 5
Table 5 – Solver Parameters

OSMSC ID
0063_2000
0063_3000
0063_4000
0064_2000
0064_3000
0064_4000
0065_2000
0065_3000
0065_4000

Time Steps per Cycle
4275
4433
5450
4275
6650
5450
4275
4433
5450

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Time Stepping Strategy
Fixed step - 4
Fixed step - 4
Fixed step - 4
Fixed step - 3
Fixed step - 3
Fixed step - 3
Fixed step - 3
Fixed step - 3
Fixed step - 3
Page 5

0075_2000
0075_3000
0075_4000
0076_2000
0076_3000
0076_4000

5. 2

4275
3325
5450
4275
4433
5450

Fixed step - 3
Fixed step - 3
Fixed step - 3
Fixed step - 4
Fixed step - 4
Fixed step - 4

Inlet Boundary Conditions

PC-MRI data was used to generate a flow waveform to be applied to the inlets of the computational fluid dynamics (CFD) model as the volumetric
inflow rate (Q). A two-part polynomial model was used to account for the effects of respiration on pressures/flow rates and superimposed on the IVC
PCMRI derived waveform [10]. No significant resspiration effects are seen in the SVC, internal jugular vien (IJV) and broncheocephilic cien (BrS)
therefore the PCMRI derived waveform with no respiration model modification was used [10].These waveforms were then modified to represent light,
moderate and heavy exercise (see Table 6 for physiological state of each simulation). See

Figure 4 for a plot of total inflow for each model. See Table 7 for the period and cardiac output for each
simulation.
Table 6 – Physiological Exercise State Simulated

OSMSC ID
0063_2000
0063_3000
0063_4000
0064_2000
0064_3000
0064_4000
0065_2000
0065_3000
0065_4000
0075_2000
0075_3000
0075_4000
0076_2000
0076_3000
0076_4000

Physiological Exercise State
Light
Moderate
Heavy
Light
Moderate
Heavy
Light
Moderate
Heavy
Light
Moderate
Heavy
Light
Moderate
Heavy

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 6

Table 7 – Inflow details from waveforms seen in
Figure 4

OSMSC ID
0063_2000
0063_3000
0063_4000
0064_2000
0064_3000
0064_4000
0065_2000
0065_3000
0065_4000
0075_2000
0075_3000
0075_4000
0076_2000
0076_3000
0076_4000

Period (sec)
1.71
1.33
1.09
1.71
1.33
1.09
1.71
1.33
1.09
1.71
1.33
1.09
1.71
1.33
1.09

SVC
1.27
1.27
1.90
0.89
0.89
1.34
0.49
0.49
0.73
1.11
1.11
1.67
0.96
0.97
1.43

Mean Flow (L/Min)
IVC
BrS
IJV
1.73
2.59
3.42
2.30
3.41
4.53
2.20
0.09
0.28
3.26
0.09
0.28
0.14
0.41
4.35
3.76
5.55
7.45
2.71
4.05
5.33
-

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Profile Type
Total
3.00
3.86
5.32
3.19
4.30
5.87
3.05
4.11
5.63
4.87
6.66
9.11
3.67
5.01
6.77

Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic
Parabolic

Page 7

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 8

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 9

Figure 4 – Inflow waveforms in L/min

5. 3 Outlet Boundary Conditions
RCR boundary conditions were applied to each outlet. Initial LPA/RPA flow splits were prescribed at 45/55, with
a 20:40:40 split between the upper, middle, and lower lobes, respectively, for both the left and right pulmonary
artery. Resistances values were decreased by 5%, 10% and 15% from calculated rest values to simulate light,
moderate and heavy exercise, respectively. See Appendix 5 for more details on RCR calculations and Exhibit 1
for the values used in each simulation.

6. Simulation Results
Simulation results were quantified for the last cardiac cycle. Paraview (Kitware, Clifton Park, NY), an opensource scientific visualization application, was used to visualize the results. A volume rendering of velocity
magnitude for three time points during the cardiac cycle can be seen in Table 9 for each model.
Table 8 – Volume rendering velocity during max flow and min flow.

OSMSC ID
ID:
OSMSC0063
subID: 2000
Age: 3
Gender: M
ID:
OSMSC0063
subID: 3000
Age: 3
Gender: M

Max Flow

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Min Flow

Page 10

ID:
OSMSC0063
subID: 4000
Age: 3
Gender: M
ID:
OSMSC0064
subID: 2000
Age: 6
Gender: F
ID:
OSMSC0064
subID: 3000
Age: 6
Gender: F
ID:
OSMSC0064
subID: 4000
Age: 6
Gender: F
ID:
OSMSC0065
subID: 2000
Age: 5
Gender: F
ID:
OSMSC0065
subID: 3000
Age: 5
Gender: F
ID:
OSMSC0065
subID: 4000
Age: 5
Gender: F
ID:
OSMSC0075
subID: 2000
Age: 17
Gender: F

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 11

ID:
OSMSC0075
subID: 3000
Age: 17
Gender: F
ID:
OSMSC0075
subID: 4000
Age: 17
Gender: F
ID:
OSMSC0076
subID: 2000
Age: 27
Gender: F

ID:
OSMSC0076
subID: 3000
Age: 27
Gender: F

ID:
OSMSC0076
subID: 4000
Age: 27
Gender: F

Surface distribution of time-averaged blood pressure (TABP), time-averaged wall shear stress (TAWSS) and
oscillatory shear index (OSI) were also visualized and can be seen in Table 9.

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 12

Table 9 – Time averaged blood pressure (TABP), time-average wall shear stress (TAWSS), and oscillatory shear index (OSI) surface distributions

OSMSC ID
ID: OSMSC0063
subID: 2000
Age: 3
Gender: M

Time Averaged Pressure

TAWSS

OSI

ID: OSMSC0063
subID: 3000
Age: 3
Gender: M
ID: OSMSC0063
subID: 4000
Age: 3
Gender: M
ID: OSMSC0064
subID: 2000
Age: 6
Gender: F
ID: OSMSC0064
subID: 3000
Age: 6
Gender: F
ID: OSMSC0064
subID: 4000
Age: 6
Gender: F
ID: OSMSC0065
subID: 2000
Age: 5
Gender: F
ID: OSMSC0065
subID: 3000
Age: 5
Gender: F

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 13

ID: OSMSC0065
subID: 4000
Age: 5
Gender: F

ID: OSMSC0075
subID: 2000
Age: 17
Gender: F

ID: OSMSC0075
subID: 3000
Age: 17
Gender: F

ID: OSMSC0075
subID: 4000
Age: 17
Gender: F

ID: OSMSC0076
subID: 2000
Age: 27
Gender: F

ID: OSMSC0076
subID: 3000
Age: 27
Gender: F

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 14

ID: OSMSC0076
subID: 4000
Age: 27
Gender: F

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 15

7. References
[1] National Heart Blood and Lung Institute, "Congenital Heart Defects," 1 July 2011. [Online]. Available:
http://www.nhlbi.nih.gov/health/health-topics/topics/chd/. [Accessed January 2012].
[2] American Heart Association, "Common Types of Heart Defects," 2 May 2011. [Online]. Available:
http://www.heart.org/HEARTORG/Conditions/CongenitalHeartDefects/AboutCongenitalHeartDefects/CommonTypes-of-Heart-Defects_UCM_307017_Article.jsp#.TwHuCNQS01I. [Accessed Januaray 2012].
[3] A. Marelli, A. Mackie, R. Ionescu-Ittu, E. Rahme and L. Pilote, "Congenital Heart Disease in the General
Population: Changing Prevalence and Age Distribution," Circulation, vol. 115, pp. 163-172, 2007.
[4] Cincinnati Children's, "Single Ventricle Anomalies and Fontan Circulation," March 2010. [Online]. Available:
http://www.cincinnatichildrens.org/health/s/sv/. [Accessed January 2012].
[5] S. Nayak and P. Booker, "The Fontan Circulation," British Journal of Anaesthesia, vol. 8, no. 1, pp. 26-30, 2008.
[6] A. M. Rudolph, "Aortic atresia, mitral atresia, and hypoplastic left ventricle," in Congenital Disease of the Heart:
Clinical Physioloical Considerations, Hoboken, Blackwell Publishing, 2009, pp. 257-288.
[7] Children's Hospital of Wisconsin, "Norwood Procedure of Hypoplastic Left Heart Syndrome," 2012. [Online].
Available: http://www.chw.org/display/router.asp?DocID=21364#. [Accessed 24 May 2012].
[8] S. Yuan and H. Jing, "Palliative Procedures for Congenital Heart Defects," Archives of Cardiovascular Disease, vol.
102, pp. 549-557, 2009.
[9] A. L. Marsden, I. E. Vignon-Clmentel, F. P. Chan, J. A. Feinstein and C. A. Taylor, "Effects of exercise and
respiration on hemodynamics efficiency in CFD simulations of the total cavopulmonary connection," Annals of
Biomedical Engineering, vol. 35, no. 2, pp. 250-263, 2007.
[10] A. L. Marsden, M. Reddy, S. Shadden, F. Chan, C. Taylor and J. Feinstein, "A New Multiparameter Approach to
Computational Simulation for Fontan Assessment and Redesign," Congenit Heart Dis., vol. 5, pp. 104-117, 2010.

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 16

Exhibit 1: Simulation RCR Values
Table 10 – RCR Values for 0063 Simulations in cgs units

ID

Face Name

0063_2000

0063_3000

0063_4000

Rp

C

Rd

Rp

C

Rd

Rp

C

Rd

2

LPA_ul1_final

1127.88

2.31E-05

5643.97

1092.95

2.39E-05

5322.49

1057.86

2.48E-05

5001.17

3

LPA_ul2_final

1321.63

2.10E-05

6301.55

1281.03

2.18E-05

5940.93

1240.29

2.26E-05

5580.45

4

LPA_ulbr_final

1039.27

2.14E-05

6015.93

1006.24

2.21E-05

5677.64

973.09

2.29E-05

5339.46

5

LPA_ul_final

1039.25

2.14E-05

6015.78

1006.22

2.21E-05

5677.49

973.08

2.29E-05

5339.32

6

LPA_ml_final

1381.99

1.85E-05

6882.10

1339.00

1.92E-05

6490.13

1295.88

1.99E-05

6098.30

7

LML_final

1103.90

2.37E-05

5423.09

1070.13

2.45E-05

5113.33

1036.21

2.55E-05

4803.73

8

LMML_final

1524.26

1.33E-05

9340.23

1474.05

1.38E-05

8818.62

1423.71

1.43E-05

8297.14

9

LML2_final

1806.75

1.20E-05

11833.07

1750.53

1.24E-05

11171.40

1694.69

1.28E-05

10509.36

10

LPA_br1_final

1087.54

2.06E-05

6301.37

1052.60

2.13E-05

5947.42

1017.70

2.21E-05

5593.43

11

LPA

802.46

3.32E-05

4483.58

779.78

3.44E-05

4228.04

757.00

3.57E-05

3972.61

12

LPA_llbr_final

1792.28

1.06E-05

12951.34

1735.88

1.10E-05

12231.76

1679.33

1.13E-05

11512.33

13

RPA_br3_final

778.56

4.24E-05

3527.56

757.02

4.40E-05

3322.46

735.36

4.58E-05

3117.49

14

RPA_br2_final

1499.00

1.70E-05

7710.20

1461.84

1.79E-05

7262.67

1414.84

1.86E-05

6824.98

15

RPA_mmbr_final

1308.75

1.36E-05

8559.66

1262.89

1.40E-05

8086.13

1216.93

1.45E-05

7612.70

16

RUML2_final

1759.44

1.77E-05

7800.32

1706.71

1.84E-05

7349.90

1653.80

1.91E-05

6899.66

17

RPA_mm_final

1730.89

1.41E-05

9586.74

1676.83

1.46E-05

9045.14

1622.59

1.51E-05

8503.71

18

RPA_ml_final

895.62

2.95E-05

5160.09

869.40

3.05E-05

4867.59

842.90

3.16E-05

4575.36

19

RPA_mlbr_final

759.26

4.29E-05

3741.11

739.88

4.45E-05

3523.64

720.36

4.63E-05

3306.29

20

RPA_br1_final

565.82

6.13E-05

2432.84

550.23

6.37E-05

2290.61

534.56

6.63E-05

2148.45

21

RPA

542.90

6.95E-05

2329.48

529.02

7.21E-05

2192.18

515.03

7.51E-05

2054.99

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 17

Table 11 – RCR Values for 0064 Simulations in cgs units

ID

Face Name

0064_2000

0064_3000

0064_4000

Rp

C

Rd

Rp

C

Rd

Rp

C

Rd

2

LUL2_final

2042.85

8.16E-06

13869.24

1967.25

8.42E-06

13107.36

1891.55

8.71E-06

12345.58

3

LUL2b_final

2587.57

5.04E-06

20610.13

2494.82

5.23E-06

19481.94

2395.29

5.40E-06

18360.54

4

LUL

1327.34

1.24E-05

9426.42

1280.32

1.28E-05

8907.45

1233.22

1.32E-05

8388.57

5

LUML2_final

2346.34

6.71E-06

17911.18

2258.21

6.92E-06

16933.12

2169.98

7.15E-06

15955.16

6

LPA_2_final

806.66

3.71E-05

4336.45

785.31

3.85E-05

4087.11

763.83

4.00E-05

3837.91

7

LPA_3_final

1088.38

2.40E-05

5280.54

1055.36

2.49E-05

4978.36

1022.19

2.59E-05

4676.32

8

LML

1139.07

2.24E-05

5749.67

1113.09

2.36E-05

5413.08

1077.18

2.45E-05

5086.43

9

LPA_4_final

888.49

2.98E-05

5080.51

862.63

3.08E-05

4792.21

836.46

3.19E-05

4504.23

10

LPA_final

751.77

4.10E-05

3470.49

730.04

4.25E-05

3269.99

708.21

4.42E-05

3069.60

11

PA_ex2_final

1800.86

1.51E-05

9040.73

1745.75

1.56E-05

8525.23

1690.45

1.62E-05

8009.92

12

RUL

848.89

3.46E-05

4523.91

825.94

3.58E-05

4264.07

802.87

3.72E-05

4004.37

13

RUL_3_final

1532.97

1.62E-05

8092.11

1485.04

1.68E-05

7633.45

1436.94

1.74E-05

7174.98

14

RUL4_final

3397.45

4.83E-06

22343.16

3286.60

5.02E-06

21099.24

3160.57

5.19E-06

19870.50

15

RUL_2_final

1072.31

2.02E-05

6488.00

1037.95

2.08E-05

6124.45

1003.23

2.16E-05

5761.26

16

RML_final

564.99

6.56E-05

2225.89

552.04

7.01E-05

2091.95

536.39

7.31E-05

1960.71

17

RML2_final

663.02

6.15E-05

2479.78

645.49

6.40E-05

2331.89

627.82

6.67E-05

2184.16

18

RMML_final

711.22

4.15E-05

3357.54

690.53

4.30E-05

3164.09

669.73

4.47E-05

2970.74

19

RLML_final

809.91

3.70E-05

4394.28

788.49

3.84E-05

4141.79

766.93

3.99E-05

3889.45

20

RLL_2

564.26

7.72E-05

2055.14

549.85

8.03E-05

1931.69

535.32

8.38E-05

1808.36

21

RPA_final

542.74

6.95E-05

2327.89

528.86

7.22E-05

2190.68

514.88

7.51E-05

2053.58

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 18

Table 12 – RCR Values for 0065 simulations in cgs units

ID

Face Name

0065_2000

0065_3000

0065_4000

Rp

C

Rd

Rp

C

Rd

Rp

C

Rd

2

LUL2_final

1040.52

2.13E-05

6028.72

1007.42

2.21E-05

5689.75

974.21

2.29E-05

5350.89

3

LUL_final

849.57

3.64E-05

4482.30

827.24

3.77E-05

4224.01

804.76

3.92E-05

3965.87

4

LML2_final

901.23

2.93E-05

5222.75

874.73

3.03E-05

4926.94

847.97

3.14E-05

4631.38

5

LML_final

737.50

4.23E-05

3775.38

718.46

4.39E-05

3556.90

707.34

4.68E-05

3330.50

6

LUML_final

1223.09

2.16E-05

6099.03

1185.38

2.23E-05

5751.37

1155.46

2.36E-05

5395.91

7

LUML2_final

1223.15

2.16E-05

6099.55

1185.43

2.23E-05

5751.86

1155.51

2.36E-05

5396.37

8

LLL_final

978.56

2.13E-05

5991.97

947.01

2.20E-05

5656.65

915.36

2.28E-05

5321.43

9

LLL2_final

978.58

2.13E-05

5992.23

947.03

2.20E-05

5656.90

915.38

2.28E-05

5321.67

10

LPA_final

710.45

4.15E-05

3350.32

689.79

4.31E-05

3157.26

669.03

4.47E-05

2964.29

11

LLL3_final

1447.30

2.07E-05

6562.91

1403.30

2.15E-05

6185.32

1359.37

2.23E-05

5807.66

12

RUL2_final

1104.69

2.36E-05

5430.36

1070.88

2.45E-05

5120.22

1036.92

2.54E-05

4810.23

13

RUL_final

863.47

3.08E-05

4801.57

838.63

3.18E-05

4528.25

813.79

3.30E-05

4254.93

14

RPA_final

1739.28

9.18E-06

12039.52

1674.31

9.47E-06

11379.29

1609.38

9.80E-06

10719.02

15

RML4_final

1450.47

1.75E-05

7253.14

1405.12

1.81E-05

6840.41

1359.62

1.88E-05

6427.83

16

RML_final

735.90

3.71E-05

3932.11

715.15

3.84E-05

3707.18

694.17

3.99E-05

3482.48

17

RL1_final

720.73

6.27E-05

2541.10

702.12

6.53E-05

2388.03

683.40

6.82E-05

2235.08

18

RL1a_final

885.54

2.99E-05

5047.59

859.80

3.09E-05

4761.06

833.79

3.21E-05

4474.80

19

RL3b_final

1606.01

1.77E-05

7366.17

1557.07

1.84E-05

6942.89

1507.97

1.91E-05

6519.77

20

RL3_final

1606.01

1.77E-05

7366.17

1557.07

1.84E-05

6942.89

1507.97

1.91E-05

6519.77

21

RL2_new_final

745.78

3.33E-05

4153.46

722.84

3.45E-05

3918.55

699.81

3.58E-05

3683.73

22

RL2a_final

1079.24

2.43E-05

5196.75

1046.66

2.52E-05

4899.01

1013.94

2.61E-05

4601.42

23

RL1b_final

1380.18

1.85E-05

6865.63

1337.29

1.92E-05

6474.53

1294.26

1.99E-05

6083.57

24

RL3c_final

1617.80

1.50E-05

8733.40

1567.24

1.55E-05

8239.165

1516.50

1.61E-05

7745.10

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 19

Table 13 – RCR values for 0075 simulations in cgs units

ID

Face Name

0075_2000

0075_3000

0075_4000

Rp

C

Rd

Rp

C

Rd

Rp

C

Rd

2

LUL2_new_final

1565.19

1.16E-05

11157.83

1515.13

1.2E-05

10538.26

1465.33

1.24E-05

9918.43

3

LUL_new_final

1365.81

2.06E-05

6542.53

1324.04

2.1E-05

6168.07

1282.35

2.21E-05

5793.53

4

LUML2_final

2318.02

7.17E-06

16157.93

2233.28

7.4E-06

15270.25

2148.40

7.66E-06

14382.71

5

LUML3_final

2317.94

7.17E-06

16157.10

2233.20

7.4E-06

15269.46

2148.33

7.66E-06

14381.97

6

LUML_final

1492.66

1.21E-05

10281.14

1441.89

1.3E-05

9712.23

1391.54

1.30E-05

9142.92

7

LML_final

1570.94

1.40E-05

9079.89

1520.37

1.4E-05

8569.89

1469.65

1.50E-05

8060.04

8

LML2_final

1795.61

8.14E-06

14463.67

1740.11

8.5E-06

13663.41

1676.09

8.75E-06

12871.68

9

LML4_final

1795.61

8.14E-06

14463.67

1740.11

8.5E-06

13663.41

1676.09

8.75E-06

12871.68

10

LML5_final

2244.96

6.95E-06

16786.08

2162.05

7.2E-06

15867.35

2085.04

7.47E-06

14942.73

11

LLL2_final

1739.40

9.18E-06

12040.75

1674.43

9.5E-06

11380.45

1609.49

9.79E-06

10720.12

12

LLL3_final

2244.96

6.95E-06

16786.08

2162.05

7.2E-06

15867.35

2085.04

7.47E-06

14942.73

13

LLL_final

1351.20

1.21E-05

11114.85

1307.26

1.2E-05

10502.69

1263.18

1.29E-05

9890.66

14

LPA_final

1108.07

2.36E-05

5461.48

1074.10

2.4E-05

5149.69

1039.98

2.53E-05

4838.05

15

RUL_final

1375.37

1.42E-05

8359.17

1328.51

1.5E-05

7893.68

1281.54

1.52E-05

7428.30

16

RULbr3_final

4312.73

2.86E-06

36565.91

4144.25

2.9E-06

34582.88

3975.60

3.04E-06

32600.03

17

RULbr2_final

3708.82

3.72E-06

29111.51

3568.79

3.8E-06

27524.15

3428.54

3.96E-06

25937.01

18

RULbr4_final

2336.25

7.13E-06

16349.11

2250.58

7.4E-06

15451.35

2164.77

7.61E-06

14553.72

19

RULbr_final

2609.19

4.72E-06

22750.89

2508.48

4.9E-06

21516.86

2407.66

5.02E-06

20282.94

20

RML5_final

1801.23

8.44E-06

14828.41

1739.80

8.7E-06

14014.59

1678.90

9.00E-06

13200.25

21

RML2_final

1743.22

1.57E-05

8565.60

1690.27

1.6E-05

8075.99

1637.13

1.69E-05

7586.55

22

RML3_final

1442.29

1.79E-05

7332.05

1397.63

1.9E-05

6914.90

1352.82

1.93E-05

6497.90

23

RML4_final

1121.06

2.33E-05

5581.09

1086.46

2.4E-05

5262.95

1051.70

2.50E-05

4944.96

24

RML_final

1344.17

1.22E-05

11016.72

1300.57

1.3E-05

10409.75

1256.85

1.30E-05

9802.90

25

RLL_final

861.87

3.08E-05

4784.07

837.13

3.2E-05

4511.65

812.36

3.31E-05

4239.26

26

RLL2_final

1354.14

1.21E-05

11155.81

1310.05

1.2E-05

10541.49

1265.82

1.29E-05

9927.29

27

RPA_final

767.98

4.60E-05

3327.93

747.32

4.8E-05

3133.02

726.41

4.97E-05

2938.36

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 20

Table 14 – RCR Values for 0076 simulations in cgs units

ID

Face Name

0076_2000

0076_3000

0076_4000

Rp

C

Rd

Rp

C

Rd

Rp

C

Rd

2

LUL1

983.86

2.12E-05

6046.14

951.86

2.19E-05

5708.14

919.95

2.27E-05

5370.05

3

LUL2

2321.72

6.76E-06

17637.78

2234.86

6.98E-06

16674.14

2147.90

7.21E-06

15710.60

4

LML1

1116.33

2.34E-05

5537.47

1081.95

2.42E-05

5221.65

1047.43

2.51E-05

4905.97

5

LML2

1357.29

1.20E-05

11199.81

1313.04

1.24E-05

10583.16

1268.66

1.29E-05

9966.64

6

LML3

1879.68

7.55E-06

15602.22

1811.34

7.79E-06

14750.46

1742.90

8.05E-06

13898.80

7

LML4

1510.36

1.43E-05

8661.29

1460.78

1.48E-05

8175.52

1411.07

1.53E-05

7689.88

8

LLL1

1860.00

1.05E-05

12587.60

1799.99

1.08E-05

11887.21

1739.82

1.12E-05

11186.98

9

LLL2

858.14

3.31E-05

4738.31

834.72

3.43E-05

4467.18

811.17

3.56E-05

4196.18

10

LLL3

1221.75

2.16E-05

6086.60

1184.10

2.24E-05

5739.60

1154.24

2.37E-05

5384.81

11

RUL1

1662.93

8.63E-06

13287.22

1603.25

8.90E-06

12560.05

1542.28

9.20E-06

11834.17

12

RUL2

2156.23

7.25E-06

15802.57

2082.26

7.54E-06

14931.34

2002.13

7.79E-06

14066.27

13

RUL3

1764.11

8.69E-06

13832.04

1702.99

8.97E-06

13072.31

1640.70

9.27E-06

12313.75

14

RUL4

2380.73

6.63E-06

18293.17

2290.83

6.84E-06

17294.97

2200.82

7.07E-06

16296.88

15

RML1

1508.80

1.64E-05

8014.00

1462.02

1.70E-05

7559.58

1415.07

1.76E-05

7105.33

16

RML2

1083.32

2.42E-05

5234.18

1050.55

2.50E-05

4934.45

1017.63

2.60E-05

4634.87

17

RML3

775.95

3.96E-05

4057.65

755.38

4.10E-05

3823.82

734.69

4.26E-05

3590.11

18

RLL1

1751.07

1.45E-05

9202.43

1696.05

1.50E-05

8680.95

1640.84

1.56E-05

8159.66

19

RLL2

1100.12

2.38E-05

5388.38

1066.53

2.46E-05

5080.47

1032.80

2.56E-05

4772.70

20

RLL3

1443.11

1.33E-05

9280.49

1394.66

1.37E-05

8764.54

1346.09

1.42E-05

8248.71

21

RLL4

1263.26

2.09E-05

6338.64

1224.37

2.16E-05

5977.43

1185.54

2.24E-05

5616.16

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 21

Appendix
1. Image Data Orientation
The RAS coordinate system was assumed for the image data orientation. Voxel Spacing, voxel dimensions, and
physical dimensions are provided in the Right-Left (R), Anterior-Posterior (A), and Superior-Inferior (S) direction
in all specification documents unless otherwise specified.

2. Model Construction
All anatomic models were constructed in RAS Space. The models are generated by selecting centerline paths
along the vessels, creating 2D segmentations along each of these paths, and then lofting the segmentations
together to create a solid model. A separate solid model was created for each vessel and Boolean addition was
used to generate a single model representing the complete anatomic model. The vessel junctions were then
blended to create a smoothed model.

3. Physiological Assumptions
Newtonian fluid behavior is assumed with standard physiological properties. Blood viscosity and density are
given below in units used to input directly into the solver.
Blood Viscosity: 0.04 g/cm•s2
Blood Density: 1.06 g/cm3

4. Simulation Parameters
Conservation of mass and Navier-Stokes equations were solved using 3D finite element methods assuming rigid
and non-slip walls. All simulations were ran in cgs units and ran for several cardiac cycles to allow the flow rate
and pressure fields to stabilize.

5. Outlet Boundary Conditions
5.1 Resistance Methods
Resistances values can be applied to the outlets to direct flow and pressure gradients. Total
resistance for the model is calculated using relationships of the flow and pressure of the model.
Total resistance is than distributed amongst the outlets using an inverse relationship of outlet area
and the assumption that the outlets act in parallel.
5.2 Windkessel Model
In order to represent the effects of vessels distal to
the CFD model, a three-element Windkessel model
can be applied at each outlet. This model consists of
proximal resistance (Rp), capacitance (C), and distal
resistance (Rd) representing the resistance of the
proximal vessels, the capacitance of the proximal
vessels, and the resistance of the distal vessels
downstream of each outlet, respectively (Figure 1).

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Figure 5 - Windkessel model

Page 22

First, total arterial capacitance (TAC) was calculated using inflow and blood pressure. The TAC was
then distributed among the outlets based on the blood flow distributions. Next, total resistance (Rt)
was calculated for each outlet using mean blood pressure and PC-MRI or calculated target flow
(Rt=Pmean/Qdesired). Given that Rt=Rp+Rd, total resistance was distributed between Rp and Rd adjusting
the Rp to Rt ratio for each outlet.

© 2013 Open Source Medical Software Corporation. All Rights Reserved.

Page 23

